Description
Egylok (Metoprolol) Tablets 50 mg. №60 Vial
Ingredients:
Each tablet contains 50 mg of metoprolol tartrate as the active ingredient.
Mechanism of Action:
Metoprolol, a selective beta-blocker, blocks the action of natural chemicals like epinephrine in the body, leading to reduced heart rate, blood pressure, and cardiac strain.
Pharmacological Properties:
Metoprolol tartrate, the active component of Egylok tablets, selectively blocks beta-1 adrenergic receptors, exerting antihypertensive, antianginal, and antiarrhythmic effects.
Indications for Use:
Egylok tablets are indicated for the management of hypertension, angina pectoris, and heart failure.
Contraindications:
Avoid Egylok if you have a known hypersensitivity to metoprolol or other beta-blockers. Patients with certain cardiac conditions like heart block or cardiogenic shock should also avoid its use.
Side Effects:
Common side effects may include fatigue, dizziness, bradycardia, and gastrointestinal disturbances. Rare but severe side effects include bronchospasm and heart failure exacerbation.
Usage Instructions:
The typical dosage is one tablet once or twice daily, as prescribed by a healthcare provider. Swallow the tablet whole with water, and do not crush or chew it.
Benefits Compared to Analogues:
Egylok offers advantages over non-selective beta-blockers by providing cardioselective action, reducing the risk of bronchospasm in patients with asthma or chronic obstructive pulmonary disease.
Suitable Patient Groups:
Egylok can be used in adult patients, including the elderly, with caution. It is not recommended for use in children unless specifically prescribed by a pediatric specialist.
Storage Conditions and Shelf Life:
- Store Egylok at room temperature, away from moisture and heat.
- Protect from light and keep the vial tightly closed.
- Check the expiration date on the packaging and do not use expired tablets.
Packaging Description:
Egylok tablets are supplied in a vial containing 60 tablets, each labeled with the product name, strength, and batch number for traceability.
Scientific Evidence:
Metoprolol has demonstrated efficacy in managing hypertension and angina. A study in the Journal of the American College of Cardiology indicated a reduced risk of cardiovascular events in hypertensive patients treated with metoprolol.
Additional Information:
- Avoid abrupt discontinuation of Egylok to prevent rebound hypertension and worsening of angina.
- Consult a healthcare provider before initiating or discontinuing Egylok therapy, especially in patients with underlying cardiac conditions.
